跳至主要内容
临床试验/NCT03892122
NCT03892122Unknown4 期

Randomised Monocentric -Controlled Study to Evaluate the Efficacy and Stability of Dexmedetomidine Sedation Compared to Propofol Sedation in the Routinely Diagnostic Examination: Drug Induced Sleep Endoscopy

Ospedale Monsignor R. Dimiccoli, Barletta1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2019年3月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
28
试验地点
1
主要终点
adverse events during DISE

研究概览

简要总结

Obstructive Sleep Apnea Syndrome affect up 12% in adult population. It is associated with an increase rate of hypertension, metabolic syndrome, depression and adverse cardiovascular events. The evaluation of upper airway obstruction is vital to obtain site-specific treatment. Drug Induced Sleep Endoscopy (DISE) is a routinely exam which allows the direct observation of the upper airway during sedative induced sleep. Propofol and Dexmedetomidine are sedatives approved for all diagnostic examinations that required sedation.

详细描述

Obstructive Sleep Apnea Syndrome affect up 12% in adult population. It is associated with an increase rate of hypertension, metabolic syndrome, depression and adverse cardiovascular events. The evaluation of upper airway obstruction is vital to obtain site-specific treatment. Drug Induced Sleep Endoscopy is a routinely exam which allows the direct observation of the upper airway during sedative induced sleep. Propofol and Dexmedetomidine are sedatives approved for all diagnostic examinations that required sedation.

It's a Randomized Controlled study. 28 participants will be enrolled and randomized in two groups: in the first group the sedation state will be performed with Propofol, while in the second group will be used Dexmedetomidine for allow sedation state. The study will be evaluate the different hemodynamic and respiratory changes during sedation in these two different groups and differences in obstructive endoscopic anatomical patterns. This will be the first study in whic Dexmedetomidine and Propofol will be compared according to European DISE Recommendation published in august 2018 (references)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Apnea-Hypopnea Index (AHI) of 15-
  • •Men and women, age 18-65 years, Body Mass Index (BMI) < 35 Kg/m2,
  • •Awake oxygen saturation > 95%
  • •Able to read and sign the consent form

排除标准

  • •Chronic Obstructive Pulmonary Disease (COPD)
  • •Liver disease (Child Pugh 1-3)
  • •History of chronic use of sedatives, narcotics, alcohol or illicit drugs,
  • •History of 1st and 2nd degree heart block (not paced),
  • •Left Ventricular Ejection Fraction (LVEF) < 50%,
  • •Allergy to propofol or Dexmedetomidine,
  • •OSHAS (Obstructive sleep apnea/hypopnea syndrome) surgical failure patients
  • •Pregnant women.

研究组 & 干预措施

Dexmedetomidine group

Other

For the D-DISE group, dexmedetomidine will be administered with an IV infusion at 1 mcg/kg over 10 minutes, followed by a maintenance rate of 0,7 mcg/kg/h.

干预措施: Dexmedetomidine (Drug)

Propofol group

Other

Sleep endoscopy will be performed by a Target Controlled Infusion system (BRAUN perfusion system) using Schneider model in effect-site (cerebral) targeted infusion 50-ml prefilled syringe of 1% propofol. Schneider system is a complex pharmacokinetic/pharmacodynamic (PK/PD) model that allows to obtain different rates of drug from the values of age, height, weight and lean body mass of the patient

. The starting dose of propofol will be 2-2,5 mcg ml-1 and increments of 0.2 mcg ml-1 took place when the new cerebral concentration of propofol will be reached, and never before 5 minutes. In this way, the investigators will be realized a slow technique of TCI propofol infusion according to European working group

干预措施: Propofol Fresenius (Drug)

结局指标

主要结局

adverse events during DISE

时间窗: during DISE time (until 40 minutes)

Number of Participants with arterial hypotension, hypertension; number of desaturation episodes below 60%; rate of patients with heart rate below 50 beats per minute.

hert rate variation during DISE

时间窗: during DISE time (until 40 minutes)

every 5 minute will be recorded this variation and for all exam duration

systolic and diastolic blood pressure variation during DISE

时间窗: during DISE time (until 40 minutes)

every 5 minute will be recorded this variation and for all exam duration

oxygen saturation variation during DISE

时间窗: during DISE time (until 40 minutes)

every 5 minute will be recorded this variation and for all exam duration

次要结局

  • pharyngeal and laryngeal patterns during DISE(during DISE time (until 40 minutes))

研究者

发起方
Ospedale Monsignor R. Dimiccoli, Barletta
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Barbara

Director, Head of Otolaryngology

Ospedale Monsignor R. Dimiccoli, Barletta

研究点 (1)

Loading locations...

相似试验